RadNet entered into a definitive merger agreement to acquire OnRad in an all-stock and cash transaction valued at approximately $560 million. At closing, OnRad shareholders will receive $350 million in cash and 5 million shares of RadNet common stock. The deal includes a potential earn-out of up to $210 million based on OnRad achieving specific EBITDA targets for fiscal year 2027. The transaction is expected to close in early 2027, subject to regulatory approvals and customary closing conditions. RadNet operates as a national provider of outpatient diagnostic imaging services and digital health solutions.
